This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Nof Corporation, Daiichi Pharmaceutical Co., Ltd.. Active years: 2009-2013.
Company Filing History:
2 out of 342 
1 out of 200 Years Active: 2009-2013
Title: Yusuke Ohkawa: Innovator in Phospholipid Derivatives
Introduction
Yusuke Ohkawa is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of chemistry, particularly in the development of solubilizing compositions and phospholipid derivatives. With a total of 2 patents to his name, Ohkawa's work has implications in various applications, including drug delivery systems.
Latest Patents
Ohkawa's latest patents include a solubilizing composition that contains a blend of oily components, polyoxyethylenesorbitan fatty acid esters, polyhydric alcohols, and acidic phospholipids. This innovative composition is designed to enhance the solubility of various compounds. His second patent focuses on a phospholipid derivative that is highly safe for living bodies and is suitable for use in drug delivery systems such as liposomes. This derivative is characterized by its unique structural formula, which allows for versatile applications in pharmaceuticals.
Career Highlights
Throughout his career, Yusuke Ohkawa has worked with prominent companies such as Nof Corporation and Daiichi Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in the field of chemical innovations.
Collaborations
Ohkawa has collaborated with notable colleagues, including Tohru Yasukohchi and Miho Takahashi. These partnerships have likely enriched his research and development efforts, leading to advancements in his patented technologies.
Conclusion
Yusuke Ohkawa's contributions to the field of chemistry, particularly through his patents on solubilizing compositions and phospholipid derivatives, highlight his innovative spirit and dedication to advancing drug delivery systems. His work continues to influence the industry and pave the way for future innovations.